Innate immune activation in neurodegenerative disease
The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Abstract
The triggering of innate immune mechanisms is emerging as a crucial component of major neurodegenerative diseases. Microglia and other cell types in the brain can be activated in response to misfolded proteins or aberrantly localized nucleic acids. This diverts microglia from their physiological and beneficial functions, and leads to their sustained release of pro-inflammatory mediators. In this Review, we discuss how the activation of innate immune signalling pathways - in particular, the NOD-, LRR- and pyrin domain-containing 3 (NLRP3) inflammasome - by aberrant host proteins may be a common step in the development of diverse neurodegenerative disorders. During chronic activation of microglia, the sustained exposure of neurons to pro-inflammatory mediators can cause neuronal dysfunction and contribute to cell death. As chronic neuroinflammation is observed at relatively early stages of neurodegenerative disease, targeting the mechanisms that drive this process may be useful for diagnostic and therapeutic purposes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is corollary evidence for inflammation in FTD (Heneka et al., 2014), from genetic (Guerreiro et al., 2013; Rayaprolu et al., 2013; Broce et al., 2018), CSF (Sjogren et al., 2004; Woollacott et al., 2018), epidemiology (Miller et al., 2013, 2016), post-mortem (Venneti et al., 2008; Lant et al., 2014) and animal studies (Yoshiyama et al., 2007; Bhaskar et al., 2010; Yin et al., 2010).”
From Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum (2020) · cites this paper as Heneka et al., 2014
In the citing paper
“in AD, the chronic release of DAMPs, mitochondrial-released DAMPs and pro-inflammatory molecules contributes to the onset and progression of neurodegeneration [57, 76, 97, 149, 194, 270, 304, 333, 345]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“This is thought to divert microglia from performing house-keeping functions, promoting a low-grade inflammatory state and CNS damage [149, 333]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“studies have shown that cellular aging, infection, traumatic brain injury, systemic inflammation, chronic inflammatory diseases, obesity and poor oral health occurring during middle adulthood can lead to increased pro-inflammatory signals in the periphery, which may contribute to glial activation and the onset and/or perpetuation of neurodegeneration [93, 105, 149, 333]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“TLRs and associated signaling pathways contribute to both injurious and regenerative processes in CNS diseases (33–35).”
From UNC93B1 Is Widely Expressed in the Murine CNS and Is Required for Neuroinflammation and Neuronal Injury Induced by MicroRNA let-7b (2021) · cites this paper as [33]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Cited by
Items 201–300 of 1,004
Ayeni, E. A., Aldossary, A. M., Ayejoto, D. A., Gbadegesin, L. A., Alshehri, A. A., Alfassam, H. A., Afewerky, H. K., Almughem, F. A., Saidu, M. B., & Tawfik, E. A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912495 · Cited by 129
Curley, C. T., Sheybani, N., Bullock, T. N. J., & Price, R. J. (2017) · Theranostics · doi:10.7150/thno.21225 · Cited by 115
“In addition, chronic inflammation and innate immune system activation are common features of neurodegenerative diseases such as Alzheimer’s and Parkinson’s[5].”
BackgroundJaimes, Y., Naaldijk, Y., Wenk, K., Leovsky, C., & Emmrich, F. (2017) · Stem Cells · doi:10.1002/stem.2541 · Cited by 115
Immunotherapies for Neurodegenerative Diseases
Mortada, I., Farah, R., Nabha, S. M., Ojcius, D. M., Fares, Y., Almawi, W. Y., & Sadier, N. S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.654739 · Cited by 123
“Endogenous DAMPs can directly induce neuroinflammation in the CNS, shifting immunocompetent cells from their beneficial roles to a chronically reactive state, thus contributing to the progression of neurodegeneration (9).”
BackgroundXia, Y., Xiao, Y., Wang, Z.-H., Liu, X., Alam, A. M., Haran, J. P., McCormick, B. A., Shu, X., Wang, X., & Ye, K. (2023) · Nature Communications · doi:10.1038/s41467-023-41283-w · Cited by 108
“The innate immune cells involved in this process are primarily microglia and astrocytes 2 .”
Infectious disease-associated encephalopathies
Barbosa‐Silva, M. C., Lima, M. N., Battaglini, D., Robba, C., Pelosi, P. P., Rocco, P. R. M., & Maron‐Gutierrez, T. (2021) · Critical Care · doi:10.1186/s13054-021-03659-6 · Cited by 130
Rong, S., Wan, D., Fan, Y., Liu, S., Sun, K., Huo, J., Zhang, P., Li, X., Xie, X., Wang, F., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00856 · Cited by 109
Quek, H., Cuní‐López, C., Stewart, R., Colletti, T., Notaro, A., Sun, Y., Guo, C. C., Lupton, M. K., Nguyen, T. H., Oikari, L. E., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02421-1 · Cited by 122
“Activation of the innate immune response triggered by NLRP3 is the most common inflammasome pathway involved in neurodegeneration [94].”
BackgroundLinalool Inhibits LPS-Induced Inflammation in BV2 Microglia Cells by Activating Nrf2
Li, Y., Lv, O., Zhou, F., Li, Q., Wu, Z., & Zheng, Y. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1629-7 · Cited by 106
Sundaram, J. R., Poore, C. P., Sulaimee, N. H. B., Pareek, T., Cheong, W. F., Wenk, M. R., Pant, H. C., Frautschy, S. A., Low, C.-M., & Kesavapany, S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170093 · Cited by 105
“Studies have shown that neuroinflammation is associated with the development of various neurodegenerative diseases [21-23].”
Xiao, L., Zheng, H., Li, J., Wang, Q., & Sun, H. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02082-2 · Cited by 113
Proteomic analysis of aged microglia: shifts in transcription, bioenergetics, and nutrient response
Flowers, A., Bell-Temin, H., Jalloh, A., Stevens, S. M., & Bickford, P. C. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0840-7 · Cited by 103
“It is believed that this contributes to the progression of neurodegenerative diseases including AD and Parkinson’s disease [22, 37].”
BackgroundThe role of the blood–brain barrier in hypertension
Setiadi, A., Korim, W. S., Elsaafien, K., & Yao, S. T. (2017) · Experimental Physiology · doi:10.1113/ep086434 · Cited by 112
“However, another major source of inflammatory molecules is thought to arise from within the brain itself; specifically, from the glial components of the neurovascular unit, namely astrocytes and microglia (Heneka et al. 2014; Sofroniew, 2015).”
BackgroundInflammatory Cascade in Alzheimer’s Disease Pathogenesis: A Review of Experimental Findings
de Oliveira, J., Kucharska, E., Garcez, M. L., Rodrigues, M. S., Quevedo, J., Moreno-Gonzalez, I., & Budni, J. (2021) · Cells · doi:10.3390/cells10102581 · Cited by 102
“This inflammatory pathway has been increasingly described in different neurodegenerative diseases [75,90,91,95,96].”
InfluentialGarcez, M. L., Mina, F., Bellettini-Santos, T., Carneiro, F. G., Luz, A. P., Schiavo, G. L., Andrighetti, M. S., Scheid, M. G., Bolfe, R. P., & Budni, J. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.03.010 · Cited by 102
“Aβ oligomers activate microglia, which causes inflammation in the brain and promotes the production of cytokines and other inflammatory mediators that might contribute to dysfunction, injury, and ultimately neuronal loss (Ferretti et al., 2012; Heneka et al., 2014).”
BackgroundUnsupervised excitation: GABAergic dysfunctions in Alzheimer’s disease
Ambrad Giovannetti, E., & Fuhrmann, M. (2019) · Brain Research · doi:10.1016/j.brainres.2018.11.042 · Cited by 102
López González, I., Garcia-Esparcia, P., Llorens, F., & Ferrer, I. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020206 · Cited by 101
“Inflammation, as defined by microglial activation, and accompanied by astrocyte responses, together with increased expression of cytokines and mediators of the immune system in the brain and cerebrospinal fluid (CSF), is constant in all these neurodegenerative diseases and has been described in many studies and review…”
ResultMicroglia-targeting nanotherapeutics for neurodegenerative diseases
Zhao, N., Francis, N. L., Calvelli, H. R., & Moghe, P. V. (2020) · APL Bioengineering · doi:10.1063/5.0013178 · Cited by 104
Benfante, R., Lascio, S. D., Cardani, S., & Fornasari, D. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01359-4 · Cited by 108
Non‐neuronal Cells in ALS: Role of Glial, Immune cells and Blood‐CNS Barriers
Puentes, F., Malaspina, A., van Noort, J. M., & Amor, S. (2016) · Brain Pathology · doi:10.1111/bpa.12352 · Cited by 98
Cancer and Dementia: It’s Complicated
Ganguli, M. (2015) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000086 · Cited by 99
Venkataraman, A. V., Kalk, N. J., Sewell, G. W., Ritchie, C. W., & Lingford-Hughes, A. R. (2016) · Alcohol and Alcoholism · doi:10.1093/alcalc/agw092 · Cited by 118
“Microglial priming seems to be key to this (Heneka et al., 2014; Perry and Holmes, 2014).”
BackgroundMolecular features of macrophage activation
Schultze, J. L., & Schmidt, S. V. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2016.03.009 · Cited by 99
López‐Ortiz, S., Pinto-Fraga, J., Valenzuela, P. L., Martín-Hernández, J., Seisdedos, M. M., García, Ó., Toschi, N., Giuliano, F. D., Garaci, F. G., Mercuri, N. B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062897 · Cited by 115
“They represent around 12% of all brain cells [50] and are the primary component of the brain innate immune system [47,54].”
BackgroundNeuroinflammation in Post-Traumatic Stress Disorder
Lee, D.-H., Lee, J.-Y., Hong, D.-Y., Lee, E.-C., Park, S.-W., Lee, M. R., & Oh, J. S. (2022) · Biomedicines · doi:10.3390/biomedicines10050953 · Cited by 118
The role of endoplasmic reticulum stress in astrocytes
Sims, S. G., Cisney, R. N., Lipscomb, M. M., & Meares, G. P. (2021) · Glia · doi:10.1002/glia.24082 · Cited by 98
“with worsened neurological outcomes (Becher et al., 2017; Glass et al., 2010; Han et al., 2021; Heneka et al., 2014; Skaper et al., 2018).”
BackgroundGuthrie, L. N., Abiraman, K., Plyler, E. S., Sprenkle, N. T., Gibson, S. A., McFarland, B. C., Rajbhandari, R., Rowse, A. L., Benveniste, E. N., & Meares, G. P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.738021 · Cited by 106
“However, chronic glia-derived inflammation may contribute to neurodegeneration (8).”
BackgroundAndrés‐Benito, P., Moreno, J. R., Aso, E., Povedano, M., & Ferrer, I. (2017) · Aging · doi:10.18632/aging.101195 · Cited by 100
“CD68 codes for the macrophage antigen CD68 glycoprotein which is expressed by microglial cells [3537], the principal resident immune cell population in brain [38, 39].”
Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer’s disease
Taylor, J. M., Moore, Z., Minter, M. R., & Crack, P. J. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1745-4 · Cited by 97
Bibliometric Analysis of the Inflammasome and Pyroptosis in Brain
Chen, Y., Li, Y., Guo, L., Hong, J., Zhao, W., Hu, X., Chang, C., Liu, W., & Xiong, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.626502 · Cited by 92
The NLRP3 inflammasome: Role in metabolic disorders and regulation by metabolic pathways
Jiang, D., Chen, S., Sun, R., Zhang, X., & Wang, D. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.034 · Cited by 102
Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases
Dekens, D. W., Eisel, U. L. M., Gouweleeuw, L., Schoemaker, R. G., Deyn, P. P. D., & Naudé, P. J. W. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101414 · Cited by 99
“…Received 23 January 2021; Received in revised form 19 July 2021; Accepted 20 July 2021 Ageing Research Reviews 70 (2021) 101414 age-related CNS diseases, and is fundamental in the development and progression of these pathologies (Heneka et al., 2014).”
BackgroundArreola, M. A., Soni, N., Crapser, J. D., Hohsfield, L. A., Elmore, M. R. P., Matheos, D. P., Wood, M. A., Swarup, V., Mortazavi, A., & Green, K. N. (2021) · Science Advances · doi:10.1126/sciadv.abg1601 · Cited by 91
Macrophages under pressure: the role of macrophage polarization in hypertension
Harwani, S. C. (2017) · Translational research · doi:10.1016/j.trsl.2017.10.011 · Cited by 101
Taylor, X., Cisternas, P., You, Y., You, Y., Xiang, S., Marambio, Y., Zhang, J., Vidal, R., & Lasagna-Reeves, C. A. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01900-7 · Cited by 91
Batista, A. F., Rody, T., Forny-Germano, L., Cerdeiro, S., Bellio, M., Ferreira, S. T., Munoz, D. P., & De Felice, F. G. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02099-x · Cited by 91
Neuroinflammation in motor neuron disease
Endo, F., Komine, O., & Yamanaka, K. (2016) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12309 · Cited by 91
Wiciński, M., Socha, M., Malinowski, B., Wódkiewicz, E., Walczak, M., Górski, K., Słupski, M., & Pawlak-Osińska, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051050 · Cited by 89
“While the acute immune response may initially create a positive impact by increasing misfolded protein clearance, the chronic activation of inflammatory pathways may lead to neuronal damage [111,112].”
BackgroundNG2 glial cells regulate neuroimmunological responses to maintain neuronal function and survival
Nakano, M., Tamura, Y., Yamato, M., Kume, S., Eguchi, A., Takata, K., Watanabe, Y., & Kataoka, Y. (2017) · Scientific Reports · doi:10.1038/srep42041 · Cited by 89
Salech, F., Ponce, D. P., Paula-Lima, A. C., SanMartín, C. D., & Behrens, M. I. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00255 · Cited by 99
“It is proposed that the constant presence of Aβ would turn microglia “exhausted” and ineffective in the long run (McGeer and McGeer, 1998; Heneka et al., 2014; Heppner et al., 2015; Navarro et al., 2018).”
BackgroundSterile Neuroinflammation and Strategies for Therapeutic Intervention
Banjara, M., & Ghosh, C. (2017) · International Journal of Inflammation · doi:10.1155/2017/8385961 · Cited by 86
Soluble TREM2 changes during the clinical course of Alzheimer’s disease: A meta-analysis
Liu, D., Cao, B., Zhao, Y., Huang, H., McIntyre, R. S., Rosenblat, J. D., & Zhou, H. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.08.038 · Cited by 87
Epigenetic Mechanisms of Inflammasome Regulation
Poli, G., Fabi, C., Bellet, M. M., Costantini, C., Nunziangeli, L., Romani, L., & Brancorsini, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165758 · Cited by 80
“Inflammasomes containing NLRP3 are highly expressed in microglia, and they are essential to the process of neuroinflammation [124].”
BackgroundWu, P.-J., Hung, Y.-F., Liu, H.-Y., & Hsueh, Y.-P. (2017) · Neuroimmunomodulation · doi:10.1159/000477092 · Cited by 84
Decoding Mast Cell-Microglia Communication in Neurodegenerative Diseases
Sandhu, J. K., & Kulka, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031093 · Cited by 92
“oxide synthase (iNOS) and nicotinamide adenosine dinucleotide phosphate (NADPH) oxidase system [17,81].”
BackgroundInfluentialThe Mitochondria-Regulated Immune Pathway Activated in the C. elegans Intestine Is Neuroprotective
Chikka, M. R., Anbalagan, C., Dvorak, K., Dombeck, K., & Prahlad, V. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.077 · Cited by 93
“Activated microglia observed in a variety of degenerative neurological conditions, such as Parkinson’s disease (PD), Pick’s disease, amyotrophic lateral sclerosis (ALS), and Huntington’s disease, actively contribute to disease progression (Heneka et al., 2014).”
Wu, M., Xu, L., Wang, Y., Zhou, N., Zhen, F., Zhang, Y., Qu, X., Fan, H., Liu, S., Chen, Y., et al. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.09.014 · Cited by 89
Microglial NLRP3 inflammasome activation in multiple sclerosis
(2020) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.08.007 · Cited by 83
Cox, D. J., Field, R. H., Williams, D. G., Baran, M., Bowie, A. G., Cunningham, C., & Dunne, A. (2015) · Glia · doi:10.1002/glia.22786 · Cited by 82
“In contrast, nucleic acid sensors have been implicated in the recognition of host-derived nucleic acids that are aberrantly localized or released under conditions of cellular stress or injury and are therefore thought to negatively impact on a number of disease pathologies (de Rivero Vaccari et al., 2012; Heneka et al…”
BackgroundInfluentialClark, L. F., & Kodadek, T. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00042 · Cited by 82
Exercise and Neuroinflammation in Health and Disease
Seo, D.-Y., Heo, J.-W., Ko, J. R., & Kwak, H.-B. (2019) · International Neurourology Journal · doi:10.5213/inj.1938214.107 · Cited by 88
“the early stages of AD, microglia are activated, leading to the production and secretion of neurotoxic cytokines such as TNF-α and IL-1β, the generation of ROS, the inhibition of neuroprotective effects, and mitochondrial dysfunction [50,51].”
BackgroundHashemiaghdam, A., & Mroczek, M. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577185 · Cited by 81
Mechanisms of dietary flavonoid action in neuronal function and neuroinflammation
Jaeger, B. N., Parylak, S., & Gage, F. H. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.11.003 · Cited by 86
Sun, Q., Wang, S., Chen, J., Cai, H., Huang, W., Zhang, Y., Wang, L., & Xing, Y. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28907 · Cited by 85
“Nod‐like receptor protein 3 (Nlrp3), a central component of the NLRP3 inflammasome, is activated in various neurodegenerative diseases, such as AD and amyotrophic lateral sclerosis (ALS; Heneka et al., 2014).”
BackgroundWalter, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.704981 · Cited by 80
“Neuroinflammation is a common feature of neurodegenerative diseases and characterized by micro- and astrogliosis and increased levels of proinflammatory cytokines (12, 13).”
BackgroundDense hydroxyl polyethylene glycol dendrimer targets activated glia in multiple CNS disorders
Sharma, A., Sharma, R. B., Zhang, Z., Liaw, K., Kambhampati, S. P., Porterfield, J. E., Lin, K. C., DeRidder, L. B., Kannan, S., & Kannan, R. M. (2020) · Science Advances · doi:10.1126/sciadv.aay8514 · Cited by 85
Epigenetics in Alzheimer’s Disease
Gao, X., Chen, Q., Yao, H., Tan, J., Liu, Z., Zhou, Y., & Zou, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.911635 · Cited by 97
Wilkins, H. M., Carl, S. M., Weber, S. G., Ramanujan, S. A., Festoff, B. W., Linseman, D. A., & Swerdlow, R. H. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142334 · Cited by 79
“Amyloid β protein (Aβ), which aggregates in AD, induces inflammation [9] but this does not exclude the possibility that other intrinsically generated molecules might also contribute.”
BackgroundThe Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases
Sommer, A., Winner, B., & Prots, I. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0222-8 · Cited by 79
“While the role of innate immune cells is frequently described in all three here mentioned diseases [6, 7], the * Correspondence: iryna.”
BackgroundFarombi, E. O., Awogbindin, I. O., Farombi, T., Oladele, J. O., Izomoh, E. R., Aladelokun, O. B., Ezekiel, I. O., Adebambo, O. I., & Abah, V. O. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.03.005 · Cited by 87
The Links between Cardiovascular Diseases and Alzheimer's Disease
Leszek, J., Вячеславовна, М. Е., Belousov, D. M., Koutsouraki, E., Szczechowiak, K., Kobusiak−Prokopowicz, M., Mysiak, A., Diniz, B. S., Somasundaram, S. G., Kirkland, C. E., et al. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200729093724 · Cited by 115
“TLR-4 and TLR-6 receptors are suggested to be co-expressed with cell surface co-receptor (CD36, CD14) [141, 142, 145-147].”
BackgroundInfluentialAmyloid beta acts synergistically as a pro-inflammatory cytokine
LaRocca, T. J., Cavalier, A. N., Roberts, C. M., Lemieux, M. R., Ramesh, P., Garcia, M. A., & Link, C. D. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105493 · Cited by 78
“Neuroinflammation is characterized by increased production of pro-inflammatory cytokines in the CNS, especially by microglia and astroglia [7, 8].”
BackgroundReprogramming of macrophages — new opportunities for therapeutic targeting
Schultze, J. L. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.09.007 · Cited by 86
Small Molecule Binding to Alzheimer Risk Factor CD33 Promotes Aβ Phagocytosis
Miles, L. A., Hermans, S. J., Crespi, G. A. N., Gooi, J. H., Doughty, L., Nero, T. L., Markulić, J., Ebneth, A., Wroblowski, B., Oehlrich, D., et al. (2019) · iScience · doi:10.1016/j.isci.2019.07.023 · Cited by 78
Microglia-Mediated Regulation of Neuropathic Pain: Molecular and Cellular Mechanisms
Tsuda, M. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00715 · Cited by 89
Katzeff, J. S., Bright, F., Lo, K., Kril, J. J., Connolly, A. M., Crossett, B., Ittner, L. M., Kassiou, M., Loy, C. T., Hodges, J. R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70687-7 · Cited by 80
SFRP1 modulates astrocyte-to-microglia crosstalk in acute and chronic neuroinflammation
Rueda‐Carrasco, J., Martín‐Bermejo, M. J., Pereyra, G., Mateo, M. I., Borroto, A., Brosseron, F., Kummer, M. P., Schwartz, S., López‐Atalaya, J. P., Alarcón, B., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051696 · Cited by 82
“…by the Bonferroni multiple comparisons test. immunoreactivity was accumulated around the injection site (Fig 2A and B), and many cells had a round amoeboid morphology and a significantly higher CD45 expression (Figs 2B and EV1D), characteristics of activated microglia (Heneka et al , 2014).”
Self-citationZhao, Y., Chen, X., Wu, Y., Wang, Y., Li, Y., & Xiang, C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00140 · Cited by 83
“It is widely acknowledged that IL-4 is a pivotal anti-inflammatory cytokine that enhances the alternative phenotype of activated microglia in vivo and improves Aβ removal (Heneka et al., 2014; Latta et al., 2015).”
BackgroundMa, L., Yang, C., Zhang, X., Li, Y., Wang, S. L., Zheng, L., & Huang, K. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.003 · Cited by 80
Redox Signaling, Neuroinflammation, and Neurodegeneration
Aguilera, G., Colín-González, A. L., Rangel‐López, E., Chavarría, A., & Santamaría, A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7099 · Cited by 92
“In addition, NO, O 2 (cid:2) - , hydrogen peroxide (H 2 O 2 ), peroxynitrite (ONOO - ), and hydroxyl radical ( (cid:2) OH) are produced (51, 90, 169, 191, 233).”
Endoplasmic reticulum stress, an important factor in the development of Parkinson’s disease
Mou, Z., Yuan, Y., Zhang, Z., Song, L.-K., & Chen, N. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.01.019 · Cited by 79
Nzou, G., Wicks, R. T., VanOstrand, N. R., Mekky, G. A., Seale, S. A., El-Taibany, A. A., Wicks, E. E., Nechtman, C. M., Marrotte, E. J., Makani, V. S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66487-8 · Cited by 90
Neurovascular Inflammaging in Health and Disease
Mészáros, Á., Molnár, K., Nógrádi, B., Hernádi, Z., Nyúl-Tóth, Á., Wilhelm, I., & Krizbai, I. A. (2020) · Cells · doi:10.3390/cells9071614 · Cited by 77
Mehrzad, J., Malvandi, A. M., Alipour, M. A., & Hosseinkhani, S. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.07.902 · Cited by 79
“pathophysiological conditions like neurodegenerative and immune-mediated neural diseases (Heneka et al. 2014; Rolls et al. 2007).”
Chen, S.-H., Oyarzabal, E. A., & Hong, J.-S. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.10.001 · Cited by 76
“At this stage, microglia are recruited to clear these signals by preventing infection or restoring injuries in the brain [16].”
BackgroundCerami, C., Iaccarino, L., & Perani, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050993 · Cited by 75
“, interleukin 1β (IL-1β) and tumor necrosis factor α (TNF-α) [3].”
BackgroundInfluentialMalko, P., Syed Mortadza, S. A., McWilliam, J., & Jiang, L.-H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00239 · Cited by 74
Efficacy and mechanism of cGAMP to suppress Alzheimer’s disease by elevating TREM2
Xu, Q., Xu, W., Cheng, H., Yuan, H., & Tan, X. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.07.004 · Cited by 75
Ahmadi, H., Nayeri, Z., Minuchehr, Z., Sabouni, F., & Mohammadi, M. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233088 · Cited by 74
“These PRRs are capable of stimulating the microbial molecules which are known as pathogen-associated molecular patterns (PAMPs) [6].”
BackgroundInnate immune activation in Alzheimer’s disease
Wang, M.-M., Miao, D., Cao, X.-P., Tan, L., & Tan, L. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.04.20 · Cited by 72
Autophagy in Astrocytes and its Implications in Neurodegeneration
Sung, K., & Jiménez-Sánchez, M. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.041 · Cited by 80
Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease
Uddin, M. S., Kabir, M. T., Jalouli, M., Rahman, M. A., Jeandet, P., Behl, T., Alexiou, A. T., Albadrani, G. M., Abdel‐Daim, M. M., Perveen, A., et al. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210826130210 · Cited by 81
“The modulation of neurodegenerative disorders via certain immune molecules as reported in preclinical studies as well as the upregulation of inflammatory genes in tissues derived from individuals with CNS diseases, indicate a link between neurodegeneration including AD and inflammation and suggest the early involvemen…”
BackgroundA comprehensive profile of ChIP-Seq-based PU.1/Spi1 target genes in microglia.
Satoh, J.-I., Asahina, N., Kitano, S., & Kino, Y. (2014) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s19711 · Cited by 74
Watson, P. M. D., Kavanagh, E., Allenby, G., & Vassey, M. (2017) · SLAS Discovery · doi:10.1177/2472555217691450 · Cited by 74
“The role of glia as drivers of human neurodegenerative diseases, as opposed to being simply responders that have the potential to exacerbate damage, has been an area of intense debate for decades.(17) The aforementioned advances in sequencing technology during the past decade have opened the door for increasingly larg…”
BackgroundCantacorps, L., Alfonso‐Loeches, S., Moscoso‐Castro, M., Cuitavi, J., Gracia‐Rubio, I., López‐Arnau, R., Escubedo, E., Guerri, C., & Valverde, O. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.034 · Cited by 86
“, 2016) as alterations in glial cell function may affect neuronal development and survival, contributing to neurodegeneration and subsequently impairing brain connectivity and functioning (Glass et al., 2010; Guizzetti et al., 2014; Heneka et al., 2014; Wilhelm and Guizzetti, 2015).”
Weis, G. C. C., Assmann, C. E., Mostardeiro, V. B., Alves, A. D. O., da Rosa, J. R., Pillat, M. M., de Andrade, C. M., Schetinger, M. R. C., Morsch, V. M., da Cruz, I. B. M., et al. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.130417 · Cited by 76
Bellezza, I., Grottelli, S., Costanzi, E., Scarpelli, P. T., Pigna, E., Morozzi, G., Mezzasoma, L., Peirce, M. J., Moresi, V., Adamo, S., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0502-x · Cited by 80
Cholinergic Modulation of the Immune System in Neuroinflammatory Diseases
Reale, M., & Costantini, E. (2021) · Diseases · doi:10.3390/diseases9020029 · Cited by 82
“AChE inhibitors, the most used drugs of AD treatment to slow neurodegeneration, induce a synaptic increase in ACh and a direct stimulation of ACh receptors, and may affect the inflammatory activity of cells participating in AD-associated inflammation, inducing a Th1 to Th2 switch [93] and decreasing inflammation by a…”
BackgroundAnti-inflammatory role of GM1 and other gangliosides on microglia
Galleguillos, D., Wang, Q., Steinberg, N., Zaidi, A. K., Shrivastava, G., Dhami, K., Daskhan, G. C., Schmidt, E. N., Dworsky-Fried, Z., Giuliani, F., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02374-x · Cited by 78
Dimethyl fumarate: A review of preclinical efficacy in models of neurodegenerative diseases
Majkutewicz, I. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175025 · Cited by 69
Rice bran derivatives alleviate microglia activation: possible involvement of MAPK pathway
Bhatia, H. S., Baron, J., Hagl, S., Eckert, G. P., & Fiebich, B. L. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0615-6 · Cited by 77
“flammation [5].”
BackgroundHorváth, I., Iashchishyn, I. A., Moskalenko, R., Wang, C., Wärmländer, S. K. T. S., Wallin, C., Gräslund, A., Kovács, G. G., & Morozova‐Roche, L. A. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1210-9 · Cited by 79
“The most obvious common denominator in major neurodegenerative diseases, including PD and Alzheimer’s disease, is neuroinflammation [10, 11].”
BackgroundMice deficient in NRROS show abnormal microglial development and neurological disorders
Wong, K., Noubade, R., Manzanillo, P., Ota, N., Foreman, O., Hackney, J. A., Friedman, B. A., Pappu, R., Scearce-Levie, K., & Ouyang, W. (2017) · Nature Immunology · doi:10.1038/ni.3743 · Cited by 71
Zhan, L., Xie, Q., & Tibbetts, R. S. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu493 · Cited by 77
E. Hirbec, H., Noristani, H. N., & Perrin, F. E. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00227 · Cited by 71
“Interestingly, genome wide association study (GWAS) analyses of sporadic AD cases have shown that variants of highly expressed microglial transcripts (including: membranespanning 4-domains sub family A member 6A (Ms4a6a), Cd33 and Trem2, are associated with an increased risk of AD, thus suggesting that microglia play…”
BackgroundHuang, B., He, D., Chen, G., Ran, X., Guo, W., Kan, X., Wang, W., Liu, D., Fu, S., & Liu, J. (2018) · Food & Function · doi:10.1039/c8fo00057c · Cited by 78
Neuroinflammation in Synucleinopathies
Lim, S., Chun, Y., Lee, J. S., & Lee, S. (2016) · Brain Pathology · doi:10.1111/bpa.12371 · Cited by 78
“Neuroinflammation is one of the common pathological characteristics of major neurodegenerative diseases such as AD and PD (26).”
BackgroundNLRP3 Inflammasomes in Parkinson’s disease and their Regulation by Parkin
Yan, Y., Fang, Y., Zheng, R., Pu, J., & Zhang, B. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.08.004 · Cited by 77
Qiang, W., Cai, W., Yang, Q., Yang, L., Dai, Y., Zhao, Z., Yin, J., Li, Y., Li, Q., Wang, Y., et al. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.10.041 · Cited by 72
Sliz, E., Kalaoja, M., Ahola-Olli, A., Raitakari, O., Perola, M., Salomaa, V., Lehtimäki, T., Karhu, T., Viinamäki, H., Salmi, M., et al. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2018-105965 · Cited by 60
Metadata
- Authors
- Heneka, M. T., Kummer, M. P., & Latz, E.
- Affiliations
- University of Bonn (DE)
- Corresponding author
- Heneka, Michael T.
- Venue
- Nature Reviews Immunology
- Published
- 2014-06-25
- Volume
- 14
- Issue
- 7
- Pages
- 463-477
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1986611577
- Cited by
- 1,437
- References
- 171
- Citations by year
- 2026: 109 · 2025: 137 · 2024: 118 · 2023: 104 · 2022: 125 · 2021: 143 · 2020: 158 · 2019: 117 · 2018: 116 · 2017: 106 · 2016: 96 · 2015: 97 · 2014: 9
- FWCI
- 8.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- innate immunity, neurodegenerative diseases, neuroinflammation, microglia, NLRP3 inflammasome, NOD-like receptors, misfolded proteins, pro-inflammatory mediators, neuronal dysfunction, neuronal cell death, neurodegeneration therapy
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Brain, Carrier Proteins, Humans, Immunity, Innate, Inflammation, Signal Transduction, Cytokines, Amyloid beta-Peptides, Reactive Oxygen Species, Protein Folding, Microglia, Oxidative Stress, Neurodegenerative Diseases, Reactive Nitrogen Species, Receptors, Pattern Recognition, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.